Cat. No. 5041
Chemical Name: (3R)-2-Oxo-3-[[(2S)-2-Pyrrolidinylc
Biological ActivityAllosteric modulator of dopamine D2 receptors. Prevents and reverses behavioral and biochemical abnormalities in an amphetamine-sensitized animal model of schizophrenia.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Data Sheet
Beyaert et al (2013) PAOPA, a potent dopamine D2 receptor allosteric modulator, prevents and reverses behavioral and biochemical abnormalities in an amphetamine-sensitized preclinical animal model of schizophrenia. Eur.Neuropsychopharmacol. 23 253. PMID: 22658400.
Dyck et al (2011) PAOPA, a potent analogue of Pro-Leu-glycinamide and allosteric modulator of the dopamine D2 receptor, prevents NMDA receptor antagonist (MK-801)-induced deficits in social interaction in the rat: implications for the treatment of negative symptoms in schizophrenia. Schizophr.Res. 125 89. PMID: 21036015.
Tan et al (2011) Preclinical pharmacokinetic and toxicological evaluation of MIF-1 peptidomimetic, PAOPA: examining the pharmacology of a selective dopamine D2 receptor allosteric modulator for the treatment of schizophrenia. Peptides 42 89. PMID: 23416534.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses PAOPA from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: PAOPA, supplier, Dopamine, D2, receptor, allosteric, modulators, dopaminergic, schizophrenia, Tocris Bioscience, D2 Receptor Modulator products
Find multiple products by catalog number
April 1 - 5, 2017
Washington, D.C., USA